1. Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice
   Soo-A Kim et al, 2018, Aging CrossRef
2. The emerging role of AMP-activated protein kinase in cholestatic liver diseases
   Xiaojiaoyang Li et al, 2017, Pharmacological Research CrossRef
3. New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin‐like growth factor/AKT/mammalian target of rapamycin pathways
   Thuy Giang Lam et al, 2018, Cancer Science CrossRef
4. Promoting Liver Regeneration by Utilizing Liver Macrophage Metabolism
   云飞 刘, 2024, Advances in Clinical Medicine CrossRef
5. Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis
   Xiaoli Yang et al, 2018, Cell Death & Disease CrossRef
6. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation
   Xiaohui Wang et al, 2019, International Immunopharmacology CrossRef
7. IM156, a new AMPK activator, protects against polymicrobial sepsis
   Ji Hyeon Kang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
8. Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity
   Vincent Jacques et al, 2021, Hepatology Communications CrossRef
9. Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In Vitro
   Xiao-qun Han et al, 2019, Current Medical Science CrossRef
10. Theaflavine inhibits hepatic stellate cell activation by modulating the PKA/LKB1/AMPK/GSK3β cascade and subsequently enhancing Nrf2 signaling
    Guangwen Shu et al, 2023, European Journal of Pharmacology CrossRef
11. Metformin Attenuates Cyclosporine A-induced Renal Fibrosis in Rats
    Can-Xiang Lin et al, 2019, Transplantation CrossRef
12. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis
    Robert N. Willette et al, 2021, Journal of Pharmacology and Experimental Therapeutics CrossRef
13. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway
    Brigitte Grouix et al, 2018, Journal of Pharmacology and Experimental Therapeutics CrossRef
14. Harnessing metabolism of hepatic macrophages to aid liver regeneration
    Rui Liu et al, 2023, Cell Death & Disease CrossRef
15. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway
    Xiao-jie Mi et al, 2019, Journal of Agricultural and Food Chemistry CrossRef
16. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor
    Xiaoguang Gao et al, 2018, Food & Function CrossRef
17. Metabolic Reprogramming by the Excessive AMPK Activation Exacerbates Antigen-Specific Memory CD8+T Cell Differentiation after Acute Lymphocytic Choriomeningitis Virus Infection
    Jimin Son et al, 2019, Immune Network CrossRef
18. Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease
    Yang Liu et al, 2021, Archives of Biochemistry and Biophysics CrossRef
19. Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
    Ryan M. Esquejo et al, 2018, EBioMedicine CrossRef
20. Hepatoprotective Effect of Artemisia capillaris Thunb Water Extract in an Animal Model of Liver Fibrosis
    Min Ju Kim et al, 2022, Journal of the Korean Society of Food Science and Nutrition CrossRef
21. Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells
    Yun Soo Jeong et al, 2020, Pharmaceuticals CrossRef